SecurityILNS / Intellect Neurosciences, Inc. (45822W209)
IndustryPharmaceutical Preparations
Institutional Owners1
Institutional Shares37 - 0.00%
Common Shares Outstanding6,520,389 shares (as of 2016-03-31)

Institutional Stock Ownership and Shareholders

Intellect Neurosciences, Inc. (OTC:ILNS) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37 shares. Largest shareholders include Veritas Investment Management (UK) Ltd.

Intellect Neurosciences, Inc. (OTC:ILNS) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

File DateFormInvestor Opt Prev Shares Current Shares Change
Prev Value (x$1000) Current Value (x$1000) Change
2018-02-05 13F-HR Veritas Investment Management (UK) Ltd 37 37 0.00 0 0

CUSIP: 45822W209